Massimo Nabissi

Title: Massimo Nabissi: Innovator in Cancer Treatment

Introduction

Massimo Nabissi is a notable inventor based in Tolentino, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and development of new therapeutic approaches.

Latest Patents

Nabissi holds a patent for the "Use of substance P antagonists in the treatment of adenocarcinomas." This patent describes the application of neurokinin receptor antagonists, specifically targeting substance P receptors, to create a new drug effective against adenocarcinomas. The patent outlines that these antagonists possess specific characteristics, such as a pA greater than 6.0 in both human and murine tissues, and exhibit antiangiogenic effects on tumors in the genito-urinary tract. The research demonstrates a decrease in tumoral mass in tumors induced by orthotopic drafts of human tumoral cells in immunodeficient rats or mice.

Career Highlights

Throughout his career, Nabissi has focused on developing innovative treatments for cancer, particularly in the area of adenocarcinomas. His work has been instrumental in advancing the understanding of neurokinin receptors and their role in cancer therapy.

Collaborations

Nabissi has collaborated with notable colleagues, including Pierluigi Pompei and Maurizio Massi. These partnerships have contributed to the success of his research and the development of effective cancer treatments.

Conclusion

Massimo Nabissi's work in the field of cancer treatment exemplifies the impact of innovative research on medical advancements. His patent on substance P antagonists highlights the potential for new therapeutic options in combating adenocarcinomas.